Join
Live feed
·
PRReleasevia Quantisnow
Eiger BioPharmaceuticals Inc. logo

Eiger BioPharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.
EIGR· Eiger BioPharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EIGR (Eiger BioPharmaceuticals Inc.) and more on Quantisnow.